Tae Heung Kang
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 24, 2022
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer.Sung Eun Lee, Gun-Young Jang, Ji Won Lee
|Mar 01, 2022
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches.Ji Eun Won, Youngseon Byeon, Tae In Wi
|Oct 28, 2020
Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors.Gun-Young Jang, Young Seob Kim, Sung Eun Lee
|Mar 02, 2019
A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.Hyun Jin Park, Gun-Young Jang, Young Seob Kim
|Oct 06, 2018
A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells.Young Seob Kim, Hyun Jin Park, Jung Hwa Park
|Jun 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.Ga Hee Kim, Ji Eun Won, Yeongseon Byeon
Pageof 1
